RenewLog in

Get your medical card online in minutes!

Get started

Research Dashboard

Learn more from studies, search for specific conditions and get studies from all around the world in leafwell’s research dashboard.

Close
Select types
Select results
Select organ systems
Select conditions
Select cannabinoids
Select countries

Total studies done7640

66%

Positive

A total of 5024 results were found.

18%

Inconclusive

A total of 1339 results were found.

17%

Negative

A total of 1277 results were found.

Studies by Year
Studies by Organ System
Studies by Medical Condition
Studies by Country
Countries with most studies
  • United States2802
  • Canada766
  • Italy709
  • United Kingdom665
  • Germany457
  • Spain413
  • Brazil383
  • Australia367
  • China351
  • Israel289
  • France195
Studies by Cannabinoids
Endocannabinoidome
7.63%

A total of 348 studies were made for these cannabinoids.

    Acupuncture (TCM)

    Ayahuasca

    Capsaicin (CAPS)

    Cold Exposure

    Diet

    Echinacea

    Exercise

    Microbiome

    Mind-Body Medicine

    Oleoylethanolamide (OEA)

    Omega-3

    Omega-6

    Pentadecanoic acid (C15:0)

    Phycocyanin

    Resveratrol

    Turmeric

    Vitamin D

Endocannabinoids
33.96%

A total of 1549 studies were made for these cannabinoids.

    2-Arachidonoyl Glycerol (2-AG)

    Anandamide (AEA)

    Endocannabinoid (unspecified)

    Fatty Acid Amide Hydrolase (FAAH)

    Fatty Acid-Binding Protein (FABP)

    Lysophosphatidylinositol (LPI)

    Monoacylglycerol Lipase (MAGL)

    N-Arachidonoyl Dopamine (NADA)

    Other Related Compounds

    Palmitoylethanolamide (PEA)

    Pentadecanoylcarnitine (PDC)

    Virodhamine (O-AEA)

Pharmaceutical Cannabinoids
13.46%

A total of 614 studies were made for these cannabinoids.

    Pharma CBD

    Pharma THC

    Pharma THC:CBD

Phytocannabinoids
21.51%

A total of 981 studies were made for these cannabinoids.

    Cannabichromene (CBC)

    Cannabichromenic Acid (CBC-a)

    Cannabidiol (CBD)

    Cannabidiolic Acid (CBD-a)

    Cannabidivarin (CBDV)

    Cannabigerol (CBG)

    Cannabigerolic Acid (CBG-a)

    Cannabinoid (unspecified)

    Cannabinol (CBN)

    Cannabitriol (CBT)

    Delta-8-THC

    Tetrahydrocannabinolic Acid (THC-a)

    Tetrahydrocannabinol (THC)

    Tetrahydrocannabivarin (THCV)

Synthetic Cannabinoids
23.44%

A total of 1069 studies were made for these cannabinoids.

    5F-x Synthetic Cannabinoids

    Abnormal Cannabidiol (Abn-CBD)

    AB-x Synthetic Cannabinoids

    AM-x Synthetic Cannabinoids

    CP-x Synthetic Cannabinoids

    HU-x Synthetic Cannabinoids

    JWH-x Synthetic Cannabinoids

    O-x Synthetic Cannabinoids

    SR-x Synthetic Cannabinoids

    Synthetic Cannabinoid (unspecified)

    WIN-x Synthetic Cannabinoids

7640 studies

title


Prenatal Cannabis Exposure and The Risk for Neuropsychiatric Anomalies in the Offspring: A Systematic Review and Meta-AnalysisThe potential of cannabinoids in managing cancer-related anorexia in older adults: a systematic review of the literatureTherapeutic potential of cannabidiol (CBD) in anxiety disorders: A systematic review and meta-analysisThe prognostic significance of pro-BNP and heart failure in acute pulmonary embolism: A systematic reviewCannabis and anhedonia: A systematic reviewEfficacy of cannabis-based medicine in the treatment of Tourette syndrome: a systematic review and meta-analysisAntiviral Potential of Spirulina in Individuals with Human Immunodeficiency Virus or Hepatis C Virus Infections: A Systematic Review and Meta-AnalysisA systematic review of predictors of vaping cessation among young peopleCannabinoids as alleviating treatment for core symptoms of autism spectrum disorder in children and adolescents: a systematic reviewCB1 Receptor Silencing Attenuates Ketamine-Induced Hyperlocomotion Without Compromising Its Antidepressant-Like EffectsSee more results

Articles

See more posts